Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple shot replace IV antibiotics? new study explores

NCT ID NCT04434300

Knowledge-focused Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested if a powerful antibiotic called daptomycin works just as well when injected under the skin as when given through a vein. Twelve healthy volunteers received the drug both ways to compare how the body absorbs it. The goal is to find a simpler, more convenient option for patients who have trouble with IVs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

12 people

The number who actually took part.

Started

Oct 2020

Finished

Nov 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy volunteer from 18 to 65 years old * Subject determined in good health by a doctor * Signature of free and informed consent * Affiliated to the French healthcare insurance * Fluent in French Exclusion Criteria: * Active bacterial or viral infection * Immunocompromised * Body mass index \<20 or\> 30 kg / m2 * Kidney failure with glomerular filtration rate \<90ml / min / m2 calculated according to the CKD-EPI method * Known or suspected liver disease * Pregnant or lactating woman * Guardianship or curators * Any situation that could interfere with the self / hetero assessment of pain (dementia, psychiatric disorders, for example) * Concomitant intake of myotoxic drugs (statins, fibrates, ciclosporin, for example) * Allergy or known side effects to daptomycin * Dermatological pathologies which may interfere with the subcutaneous injection (eczema, psoriasis, etc.) * Localized tattoo or piercing on the abdomen which may interfere with the subcutaneous injection or the evaluation of possible local effects of the injection * Parenteral exposure to daptomycin in the previous 30 days * The inclusion of the subject in another interventional research protocol (during the present study and in the 3 months before inclusion).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antibiotics are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Antibiotics Daptomycin Subcutaneous injection

Contacts and locations

Locations

  • CHU Caen

    Caen, Normandy, 14000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.